Evidence map›Paper›PMID 31159251›Full record

ArticleCancers2019

Amplification of the

Huei-Tzu Chien, Sou-De Cheng, Chun-Ta Liao, Hung-Ming Wang, Shiang-Fu Huang

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Indian journal of surgical oncology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Prognostic Impact ofCancers · 2022
    Article
  16. Article
  17. Review
  18. Molecular Landscape of Vulvar Squamous Cell Carcinoma.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huei-Tzu ChienDepartment of Public Health, Chang Gung University, Tao-Yuan 33302, Taiwan. kathy.htchien@gmail.com.ORCID 0000-0002-4120-7070
Sou-De ChengDepartment of Anatomy, Chang Gung University, Tao-Yuan 33302, Taiwan. soude@mail.cgu.edu.tw.
Chun-Ta LiaoDepartment of Otolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Linkou branch, Tao-Yuan 33302, Taiwan. liaoct@adm.cgmh.org.tw.
Hung-Ming WangDivision of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou branch, Tao-Yuan 33302, Taiwan. whm526@adm.cgmh.org.tw.ORCID 0000-0003-0066-829X
Shiang-Fu HuangDepartment of Public Health, Chang Gung University, Tao-Yuan 33302, Taiwan. shiangfu.huang@gmail.com.ORCID 0000-0003-3582-9938

Funding

Chang Gung Memorial Hospital, Linkou CMRPG3F0671, CMRPG3F2221, CMRPG3F2222, and CMRPB53Ministry of Health and Welfare (MOHW), Executive Yuan, Taiwan, ROC. MOHW107-TDU-B-212-114016 and MOHW108-TDU-B-212-124016Ministry of Science and Technology, Executive Yuan, Taiwan, ROC. MOST106-2314-B-182-025-MY3
6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is a common cancer in Taiwan and worldwide. To provide some clues for clinical management of OSCC, 72 advanced-stage OSCCs were analyzed using two microarray platforms (26 cases with Affymetrix 500 K and 46 cases with Affymetrix SNP 6.0). Genomic identification of significant targets in cancer analyses were used to identify significant copy number alterations (CNAs) using a

Indexed as

amplificationCCND1copy number analysisEGFRoral squamous cell carcinoma

Identifiers

PMID31159251
PMCPMC6627096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.